Global Blood Plasma Market Growth 2025-2031

October 2025 | 92 pages | ID: G8CDB417430DEN
LP Information

Abstracts

The global Blood Plasma market size is predicted to grow from US$ 426 million in 2025 to US$ 491 million in 2031; it is expected to grow at a CAGR of 2.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the ?Blood Plasma Industry Forecast? looks at past sales and reviews total world Blood Plasma sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Plasma sales for 2025 through 2031. With Blood Plasma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Plasma industry.

This Insight Report provides a comprehensive analysis of the global Blood Plasma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Plasma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Blood Plasma market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Plasma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Plasma.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Plasma market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Immunoglobulin
• Albumin
• Protease Inhibitors
• Coagulation Factor Concentrates
• Others

Segmentation by Application:

• Hospitals and Clinics
• Research Laboratories
• Academic Institutions

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Baxter International
• CSL
• Grifols
• Octapharma
• ADMA Biologics
• Cerus Corp
• Sanquin
• Shanghai Raas
• TCS Biosciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Plasma market?
What factors are driving Blood Plasma market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Plasma market opportunities vary by end market size?
How does Blood Plasma break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Blood Plasma Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Blood Plasma by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Blood Plasma by Country/Region, 2020, 2024 & 2031
2.2 Blood Plasma Segment by Type
  2.2.1 Immunoglobulin
  2.2.2 Albumin
  2.2.3 Protease Inhibitors
  2.2.4 Coagulation Factor Concentrates
  2.2.5 Others
2.3 Blood Plasma Sales by Type
  2.3.1 Global Blood Plasma Sales Market Share by Type (2020-2025)
  2.3.2 Global Blood Plasma Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Blood Plasma Sale Price by Type (2020-2025)
2.4 Blood Plasma Segment by Application
  2.4.1 Hospitals and Clinics
  2.4.2 Research Laboratories
  2.4.3 Academic Institutions
2.5 Blood Plasma Sales by Application
  2.5.1 Global Blood Plasma Sale Market Share by Application (2020-2025)
  2.5.2 Global Blood Plasma Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Blood Plasma Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Blood Plasma Breakdown Data by Company
  3.1.1 Global Blood Plasma Annual Sales by Company (2020-2025)
  3.1.2 Global Blood Plasma Sales Market Share by Company (2020-2025)
3.2 Global Blood Plasma Annual Revenue by Company (2020-2025)
  3.2.1 Global Blood Plasma Revenue by Company (2020-2025)
  3.2.2 Global Blood Plasma Revenue Market Share by Company (2020-2025)
3.3 Global Blood Plasma Sale Price by Company
3.4 Key Manufacturers Blood Plasma Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Blood Plasma Product Location Distribution
  3.4.2 Players Blood Plasma Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BLOOD PLASMA BY GEOGRAPHIC REGION

4.1 World Historic Blood Plasma Market Size by Geographic Region (2020-2025)
  4.1.1 Global Blood Plasma Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Blood Plasma Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Blood Plasma Market Size by Country/Region (2020-2025)
  4.2.1 Global Blood Plasma Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Blood Plasma Annual Revenue by Country/Region (2020-2025)
4.3 Americas Blood Plasma Sales Growth
4.4 APAC Blood Plasma Sales Growth
4.5 Europe Blood Plasma Sales Growth
4.6 Middle East & Africa Blood Plasma Sales Growth

5 AMERICAS

5.1 Americas Blood Plasma Sales by Country
  5.1.1 Americas Blood Plasma Sales by Country (2020-2025)
  5.1.2 Americas Blood Plasma Revenue by Country (2020-2025)
5.2 Americas Blood Plasma Sales by Type (2020-2025)
5.3 Americas Blood Plasma Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Blood Plasma Sales by Region
  6.1.1 APAC Blood Plasma Sales by Region (2020-2025)
  6.1.2 APAC Blood Plasma Revenue by Region (2020-2025)
6.2 APAC Blood Plasma Sales by Type (2020-2025)
6.3 APAC Blood Plasma Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Blood Plasma by Country
  7.1.1 Europe Blood Plasma Sales by Country (2020-2025)
  7.1.2 Europe Blood Plasma Revenue by Country (2020-2025)
7.2 Europe Blood Plasma Sales by Type (2020-2025)
7.3 Europe Blood Plasma Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Blood Plasma by Country
  8.1.1 Middle East & Africa Blood Plasma Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Blood Plasma Revenue by Country (2020-2025)
8.2 Middle East & Africa Blood Plasma Sales by Type (2020-2025)
8.3 Middle East & Africa Blood Plasma Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Plasma
10.3 Manufacturing Process Analysis of Blood Plasma
10.4 Industry Chain Structure of Blood Plasma

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Blood Plasma Distributors
11.3 Blood Plasma Customer

12 WORLD FORECAST REVIEW FOR BLOOD PLASMA BY GEOGRAPHIC REGION

12.1 Global Blood Plasma Market Size Forecast by Region
  12.1.1 Global Blood Plasma Forecast by Region (2026-2031)
  12.1.2 Global Blood Plasma Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Blood Plasma Forecast by Type (2026-2031)
12.7 Global Blood Plasma Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Baxter International
  13.1.1 Baxter International Company Information
  13.1.2 Baxter International Blood Plasma Product Portfolios and Specifications
  13.1.3 Baxter International Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Baxter International Main Business Overview
  13.1.5 Baxter International Latest Developments
13.2 CSL
  13.2.1 CSL Company Information
  13.2.2 CSL Blood Plasma Product Portfolios and Specifications
  13.2.3 CSL Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 CSL Main Business Overview
  13.2.5 CSL Latest Developments
13.3 Grifols
  13.3.1 Grifols Company Information
  13.3.2 Grifols Blood Plasma Product Portfolios and Specifications
  13.3.3 Grifols Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Grifols Main Business Overview
  13.3.5 Grifols Latest Developments
13.4 Octapharma
  13.4.1 Octapharma Company Information
  13.4.2 Octapharma Blood Plasma Product Portfolios and Specifications
  13.4.3 Octapharma Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Octapharma Main Business Overview
  13.4.5 Octapharma Latest Developments
13.5 ADMA Biologics
  13.5.1 ADMA Biologics Company Information
  13.5.2 ADMA Biologics Blood Plasma Product Portfolios and Specifications
  13.5.3 ADMA Biologics Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 ADMA Biologics Main Business Overview
  13.5.5 ADMA Biologics Latest Developments
13.6 Cerus Corp
  13.6.1 Cerus Corp Company Information
  13.6.2 Cerus Corp Blood Plasma Product Portfolios and Specifications
  13.6.3 Cerus Corp Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Cerus Corp Main Business Overview
  13.6.5 Cerus Corp Latest Developments
13.7 Sanquin
  13.7.1 Sanquin Company Information
  13.7.2 Sanquin Blood Plasma Product Portfolios and Specifications
  13.7.3 Sanquin Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Sanquin Main Business Overview
  13.7.5 Sanquin Latest Developments
13.8 Shanghai Raas
  13.8.1 Shanghai Raas Company Information
  13.8.2 Shanghai Raas Blood Plasma Product Portfolios and Specifications
  13.8.3 Shanghai Raas Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Shanghai Raas Main Business Overview
  13.8.5 Shanghai Raas Latest Developments
13.9 TCS Biosciences
  13.9.1 TCS Biosciences Company Information
  13.9.2 TCS Biosciences Blood Plasma Product Portfolios and Specifications
  13.9.3 TCS Biosciences Blood Plasma Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 TCS Biosciences Main Business Overview
  13.9.5 TCS Biosciences Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Blood Plasma Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Blood Plasma Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunoglobulin
Table 4. Major Players of Albumin
Table 5. Major Players of Protease Inhibitors
Table 6. Major Players of Coagulation Factor Concentrates
Table 7. Major Players of Others
Table 8. Global Blood Plasma Sales by Type (2020-2025) & (K Units)
Table 9. Global Blood Plasma Sales Market Share by Type (2020-2025)
Table 10. Global Blood Plasma Revenue by Type (2020-2025) & ($ million)
Table 11. Global Blood Plasma Revenue Market Share by Type (2020-2025)
Table 12. Global Blood Plasma Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Blood Plasma Sale by Application (2020-2025) & (K Units)
Table 14. Global Blood Plasma Sale Market Share by Application (2020-2025)
Table 15. Global Blood Plasma Revenue by Application (2020-2025) & ($ million)
Table 16. Global Blood Plasma Revenue Market Share by Application (2020-2025)
Table 17. Global Blood Plasma Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Blood Plasma Sales by Company (2020-2025) & (K Units)
Table 19. Global Blood Plasma Sales Market Share by Company (2020-2025)
Table 20. Global Blood Plasma Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Blood Plasma Revenue Market Share by Company (2020-2025)
Table 22. Global Blood Plasma Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Blood Plasma Producing Area Distribution and Sales Area
Table 24. Players Blood Plasma Products Offered
Table 25. Blood Plasma Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Blood Plasma Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Blood Plasma Sales Market Share Geographic Region (2020-2025)
Table 30. Global Blood Plasma Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Blood Plasma Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Blood Plasma Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Blood Plasma Sales Market Share by Country/Region (2020-2025)
Table 34. Global Blood Plasma Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Blood Plasma Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Blood Plasma Sales by Country (2020-2025) & (K Units)
Table 37. Americas Blood Plasma Sales Market Share by Country (2020-2025)
Table 38. Americas Blood Plasma Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Blood Plasma Sales by Type (2020-2025) & (K Units)
Table 40. Americas Blood Plasma Sales by Application (2020-2025) & (K Units)
Table 41. APAC Blood Plasma Sales by Region (2020-2025) & (K Units)
Table 42. APAC Blood Plasma Sales Market Share by Region (2020-2025)
Table 43. APAC Blood Plasma Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Blood Plasma Sales by Type (2020-2025) & (K Units)
Table 45. APAC Blood Plasma Sales by Application (2020-2025) & (K Units)
Table 46. Europe Blood Plasma Sales by Country (2020-2025) & (K Units)
Table 47. Europe Blood Plasma Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Blood Plasma Sales by Type (2020-2025) & (K Units)
Table 49. Europe Blood Plasma Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Blood Plasma Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Blood Plasma Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Blood Plasma Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Blood Plasma Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Blood Plasma
Table 55. Key Market Challenges & Risks of Blood Plasma
Table 56. Key Industry Trends of Blood Plasma
Table 57. Blood Plasma Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Blood Plasma Distributors List
Table 60. Blood Plasma Customer List
Table 61. Global Blood Plasma Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Blood Plasma Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Blood Plasma Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Blood Plasma Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Blood Plasma Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Blood Plasma Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Blood Plasma Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Blood Plasma Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Blood Plasma Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Blood Plasma Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Blood Plasma Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Blood Plasma Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Blood Plasma Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Blood Plasma Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Baxter International Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 76. Baxter International Blood Plasma Product Portfolios and Specifications
Table 77. Baxter International Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Baxter International Main Business
Table 79. Baxter International Latest Developments
Table 80. CSL Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 81. CSL Blood Plasma Product Portfolios and Specifications
Table 82. CSL Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. CSL Main Business
Table 84. CSL Latest Developments
Table 85. Grifols Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 86. Grifols Blood Plasma Product Portfolios and Specifications
Table 87. Grifols Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Grifols Main Business
Table 89. Grifols Latest Developments
Table 90. Octapharma Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 91. Octapharma Blood Plasma Product Portfolios and Specifications
Table 92. Octapharma Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Octapharma Main Business
Table 94. Octapharma Latest Developments
Table 95. ADMA Biologics Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 96. ADMA Biologics Blood Plasma Product Portfolios and Specifications
Table 97. ADMA Biologics Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. ADMA Biologics Main Business
Table 99. ADMA Biologics Latest Developments
Table 100. Cerus Corp Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 101. Cerus Corp Blood Plasma Product Portfolios and Specifications
Table 102. Cerus Corp Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cerus Corp Main Business
Table 104. Cerus Corp Latest Developments
Table 105. Sanquin Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 106. Sanquin Blood Plasma Product Portfolios and Specifications
Table 107. Sanquin Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sanquin Main Business
Table 109. Sanquin Latest Developments
Table 110. Shanghai Raas Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 111. Shanghai Raas Blood Plasma Product Portfolios and Specifications
Table 112. Shanghai Raas Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Shanghai Raas Main Business
Table 114. Shanghai Raas Latest Developments
Table 115. TCS Biosciences Basic Information, Blood Plasma Manufacturing Base, Sales Area and Its Competitors
Table 116. TCS Biosciences Blood Plasma Product Portfolios and Specifications
Table 117. TCS Biosciences Blood Plasma Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. TCS Biosciences Main Business
Table 119. TCS Biosciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Blood Plasma
Figure 2. Blood Plasma Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Plasma Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Blood Plasma Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Blood Plasma Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Blood Plasma Sales Market Share by Country/Region (2024)
Figure 10. Blood Plasma Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immunoglobulin
Figure 12. Product Picture of Albumin
Figure 13. Product Picture of Protease Inhibitors
Figure 14. Product Picture of Coagulation Factor Concentrates
Figure 15. Product Picture of Others
Figure 16. Global Blood Plasma Sales Market Share by Type in 2025
Figure 17. Global Blood Plasma Revenue Market Share by Type (2020-2025)
Figure 18. Blood Plasma Consumed in Hospitals and Clinics
Figure 19. Global Blood Plasma Market: Hospitals and Clinics (2020-2025) & (K Units)
Figure 20. Blood Plasma Consumed in Research Laboratories
Figure 21. Global Blood Plasma Market: Research Laboratories (2020-2025) & (K Units)
Figure 22. Blood Plasma Consumed in Academic Institutions
Figure 23. Global Blood Plasma Market: Academic Institutions (2020-2025) & (K Units)
Figure 24. Global Blood Plasma Sale Market Share by Application (2024)
Figure 25. Global Blood Plasma Revenue Market Share by Application in 2025
Figure 26. Blood Plasma Sales by Company in 2025 (K Units)
Figure 27. Global Blood Plasma Sales Market Share by Company in 2025
Figure 28. Blood Plasma Revenue by Company in 2025 ($ millions)
Figure 29. Global Blood Plasma Revenue Market Share by Company in 2025
Figure 30. Global Blood Plasma Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Blood Plasma Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Blood Plasma Sales 2020-2025 (K Units)
Figure 33. Americas Blood Plasma Revenue 2020-2025 ($ millions)
Figure 34. APAC Blood Plasma Sales 2020-2025 (K Units)
Figure 35. APAC Blood Plasma Revenue 2020-2025 ($ millions)
Figure 36. Europe Blood Plasma Sales 2020-2025 (K Units)
Figure 37. Europe Blood Plasma Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Blood Plasma Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Blood Plasma Revenue 2020-2025 ($ millions)
Figure 40. Americas Blood Plasma Sales Market Share by Country in 2025
Figure 41. Americas Blood Plasma Revenue Market Share by Country (2020-2025)
Figure 42. Americas Blood Plasma Sales Market Share by Type (2020-2025)
Figure 43. Americas Blood Plasma Sales Market Share by Application (2020-2025)
Figure 44. United States Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Blood Plasma Sales Market Share by Region in 2025
Figure 49. APAC Blood Plasma Revenue Market Share by Region (2020-2025)
Figure 50. APAC Blood Plasma Sales Market Share by Type (2020-2025)
Figure 51. APAC Blood Plasma Sales Market Share by Application (2020-2025)
Figure 52. China Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 56. India Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Blood Plasma Sales Market Share by Country in 2025
Figure 60. Europe Blood Plasma Revenue Market Share by Country (2020-2025)
Figure 61. Europe Blood Plasma Sales Market Share by Type (2020-2025)
Figure 62. Europe Blood Plasma Sales Market Share by Application (2020-2025)
Figure 63. Germany Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 64. France Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Blood Plasma Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Blood Plasma Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Blood Plasma Sales Market Share by Application (2020-2025)
Figure 71. Egypt Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Blood Plasma Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Blood Plasma in 2025
Figure 77. Manufacturing Process Analysis of Blood Plasma
Figure 78. Industry Chain Structure of Blood Plasma
Figure 79. Channels of Distribution
Figure 80. Global Blood Plasma Sales Market Forecast by Region (2026-2031)
Figure 81. Global Blood Plasma Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Blood Plasma Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Blood Plasma Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Blood Plasma Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Blood Plasma Revenue Market Share Forecast by Application (2026-2031)